Clinical Trials Logo

Filter by:
NCT ID: NCT05014412 Active, not recruiting - Multiple Myeloma Clinical Trials

A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

MagnetisMM-9
Start date: October 7, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study (Part 1 and Part 2) is to evaluate the safety of a step-up dosing approach (starting with low doses followed by higher doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment or has not responded to treatment (relapsed/refractory multiple myeloma). This study will also look at the safety and efficacy of different doses of elranatamab, as well as different intervals between doses. Participants in the study will receive elranatamab as an injection under the skin at the study clinic. After the initial step-up doses, participants will start receiving one dose every week. The frequency of clinic visits for injections may then decrease over time. Participation will be at least two years.

NCT ID: NCT05014256 Active, not recruiting - Clinical trials for Chronic Kidney Diseases

System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

Start date: April 2, 2022
Phase: N/A
Study type: Interventional

This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and patient needs (called 'STEPS') will 1) create a program to identify people who may need a kidney transplant ('STEPS Surveillance') and find people in health systems who may be able to receive kidney transplants early in their care and (2) study how well the 'STEPS Outreach' program works (comprised of transplant social workers and transplant coordinators who focus on equality and patient needs) compared to usual care to improve access to kidney transplants among Black and non-Black individuals as well as to improve access to transplants for everyone.

NCT ID: NCT05014204 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

REGENT-1-US
Start date: October 29, 2021
Phase: N/A
Study type: Interventional

This is a multi-center, open-label study to assess the feasibility and preliminary safety of the Endogenex Device for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering medications.

NCT ID: NCT05014087 Active, not recruiting - Clinical trials for Alcohol-Induced Disorders

Digoxin In Treatment of Alcohol Associated Hepatitis

DIGIT-AlcHep
Start date: October 8, 2021
Phase: Phase 2
Study type: Interventional

Prospective, single center, open label, randomized controlled trial to determine the feasibility of conducting a future study with respect to patient recruitment, digoxin administration and dose adjustment. The study intervention will be intravenous digoxin (renal-based dosing for maximum of 28 days) versus no digoxin in an open-label 1:1 randomized allocation of patients with severe acute alcohol associated hepatitis.

NCT ID: NCT05013905 Active, not recruiting - Crohn Disease Clinical Trials

A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease

APOLLO-CD
Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of PRA023 in participants with moderately to severely active Crohn's Disease. After the completion of the 12-week induction period, all participants have the option to continue in the open-label extension for another 38 weeks.

NCT ID: NCT05013788 Active, not recruiting - Asthma in Children Clinical Trials

Using Social Media to Decrease Healthcare Utilization for Pediatric Asthma

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if social media enhanced education (SME) will reduce total number of treatment days defined as summation of days of subsequent hospital admission, emergency room visits, and clinic visits, reduce missed school days, reduce total costs from a health system perspective, have increased effect with increased social media engagement, have increased effect in participants with both caregiver and patient (combined) with social media accounts, compared to participants where only the patient or only the caregiver uses social media (single),have increased patient satisfaction in the asthma education received and to obtain the experience and data needed to refine SME to be able to expand this platform for other chronic medical conditions with high healthcare utilization including pediatric diabetes, epilepsy, and sickle cell disease in children with asthma.

NCT ID: NCT05013645 Active, not recruiting - Dry Skin Clinical Trials

Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic

DAMP
Start date: May 22, 2019
Phase: N/A
Study type: Interventional

Double-blind placebo-controlled clinical trial to evaluate the effectiveness of a sterilized probiotic on skin health and hydration in adults with dry skin. The goal of the study is to determine if the addition of a skin-conditioning probiotic to a standard gel product will moisturize the skin, support a healthy skin microbiome, and be readily tolerated by adults with dry skin.

NCT ID: NCT05013138 Active, not recruiting - Child Development Clinical Trials

Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care

Start date: April 29, 2022
Phase: N/A
Study type: Interventional

This longitudinal study will evaluate if increased caregiver awareness of their own ACEs through provider-led discussions will lead to improved child health via fewer emergency department, urgent care visits and missed primary care appointments.

NCT ID: NCT05012774 Active, not recruiting - Hearing Loss Clinical Trials

Speech Perception Training: Advanced Scoring and Feedback Methods

Start date: July 14, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to assess training of visual speech (lipreading) and audiovisual (lipreading plus auditory) speech as a rehabilitation strategy for hearing loss in adults.

NCT ID: NCT05012410 Active, not recruiting - Alzheimer Disease Clinical Trials

WeCareAdvisor Study for Caregivers of People Living With Dementia

Start date: December 13, 2021
Phase: N/A
Study type: Interventional

The WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia. The trial will evaluate its efficacy to reduce caregiver distress, improve confidence managing behaviors, as well as reduce occurrences and severity of behavioral and psychological symptoms. Visit https://wecareadvisorstudy.com/ for more information.